American Antiquities (PAWS) 0.0500 $PAWS
Praxsyn Now Licensed to Dispense Medication in Twelve States
GlobeNewswire - Thu Sep 04, 2:25PM CDT
Praxsyn Corporation (OTCQB
AWS), today announced that its subsidiary, Mesa Pharmacy Inc., a medication and service provider for medical practitioners, is making progress towards its goal of dispensing its customized medications nationwide. The company is now licensed to dispense its medications in the following twelve states:
Praxsyn Announces Progress in Filing of Form 10-Q
GlobeNewswire - Mon Jun 23, 1:59PM CDT
Praxsyn Corporation (OTCQB AWS), a medication and service provider for medical practitioners, announced that it is making progress in filing its Form 10-Q for the quarter ended March 31, 2014.
Mesa Pharmacy prescription orders for February exceed $7.4 million. Sales continue to increase in line with expectations.
PR Newswire - Wed Mar 12, 9:57AM CDT
The PAWS Pet Company, Inc. (OTCQB AWS), is pleased to announce that revised February orders at its Mesa Pharmacy, Inc. (Mesa) subsidiary generated gross revenues, excluding allowances for returns and discounts, exceeding $7.4 Million Dollars. Prescription orders for transdermal topical pain medications continue to rise.
Mesa Pharmacy prescription orders for February exceed $6.5 million. Sales continue to increase inline with expectations.
PR Newswire - Wed Feb 26, 10:35AM CST
The PAWS Pet Company, Inc. (OTCQB AWS), is pleased to announce that February orders at its Mesa Pharmacy, Inc. (Mesa) subsidiary have continued to increase inline with expectations and have generated gross revenues, excluding allowances for returns and discounts, exceeding $6.5 Million Dollars. "We are currently filling prescriptions for transdermal topical pain medications of approximately $400,000 dollars per day". Stated Andrew Do, Mesa's President and Registered Pharmacist.
The PAWS Pet Company, Inc. acquires Mesa Pharmacy. 2014 gross revenues are expected to approach $100,000,000.
PR Newswire - Thu Jan 09, 7:00AM CST
The PAWS Pet Company, Inc. (OTCQB AWS), is pleased to announce that on December 31, 2013, PAWS closed the acquisition of Mesa Pharmacy Inc. ("Mesa"
.
The PAWS Pet Company, Inc. to Acquire MESA Pharmacy of Irvine, CA
GlobeNewswire - Tue Sep 10, 6:39PM CDT
via PRWEB - The PAWS Pet Company, Inc. (OTCQB AWS) (OTCPK AWS), announced it has signed a letter of intent to acquire Pharmacy Development, Inc. dba MESA Pharmacy, of Irvine, California as part on its new strategy to be a dominant player in the delivery of pharmaceutical products to consumers.
Praxsyn Now Licensed to Dispense Medication in Twelve States
GlobeNewswire - Thu Sep 04, 2:25PM CDT
Praxsyn Corporation (OTCQB
AWS), today announced that its subsidiary, Mesa Pharmacy Inc., a medication and service provider for medical practitioners, is making progress towards its goal of dispensing its customized medications nationwide. The company is now licensed to dispense its medications in the following twelve states: Praxsyn Announces Progress in Filing of Form 10-Q
GlobeNewswire - Mon Jun 23, 1:59PM CDT
Praxsyn Corporation (OTCQB
AWS), a medication and service provider for medical practitioners, announced that it is making progress in filing its Form 10-Q for the quarter ended March 31, 2014. Mesa Pharmacy prescription orders for February exceed $7.4 million. Sales continue to increase in line with expectations.
PR Newswire - Wed Mar 12, 9:57AM CDT
The PAWS Pet Company, Inc. (OTCQB
AWS), is pleased to announce that revised February orders at its Mesa Pharmacy, Inc. (Mesa) subsidiary generated gross revenues, excluding allowances for returns and discounts, exceeding $7.4 Million Dollars. Prescription orders for transdermal topical pain medications continue to rise. Mesa Pharmacy prescription orders for February exceed $6.5 million. Sales continue to increase inline with expectations.
PR Newswire - Wed Feb 26, 10:35AM CST
The PAWS Pet Company, Inc. (OTCQB
AWS), is pleased to announce that February orders at its Mesa Pharmacy, Inc. (Mesa) subsidiary have continued to increase inline with expectations and have generated gross revenues, excluding allowances for returns and discounts, exceeding $6.5 Million Dollars. "We are currently filling prescriptions for transdermal topical pain medications of approximately $400,000 dollars per day". Stated Andrew Do, Mesa's President and Registered Pharmacist. The PAWS Pet Company, Inc. acquires Mesa Pharmacy. 2014 gross revenues are expected to approach $100,000,000.
PR Newswire - Thu Jan 09, 7:00AM CST
The PAWS Pet Company, Inc. (OTCQB
AWS), is pleased to announce that on December 31, 2013, PAWS closed the acquisition of Mesa Pharmacy Inc. ("Mesa" . The PAWS Pet Company, Inc. to Acquire MESA Pharmacy of Irvine, CA
GlobeNewswire - Tue Sep 10, 6:39PM CDT
via PRWEB - The PAWS Pet Company, Inc. (OTCQB
AWS) (OTCPK AWS), announced it has signed a letter of intent to acquire Pharmacy Development, Inc. dba MESA Pharmacy, of Irvine, California as part on its new strategy to be a dominant player in the delivery of pharmaceutical products to consumers. 
